Reduced functional brain activity response in cognitively intact apolipoprotein E epsilon4 carriers

Brain : a Journal of Neurology
J LindLars Nyberg

Abstract

The apolipoprotein E epsilon4 (APOE epsilon4) is the main known genetic risk factor for Alzheimer's disease. Genetic assessments in combination with other diagnostic tools, such as neuroimaging, have the potential to facilitate early diagnosis. In this large-scale functional MRI (fMRI) study, we have contrasted 30 APOE epsilon4 carriers (age range: 49-74 years; 19 females), of which 10 were homozygous for the epsilon4 allele, and 30 non-carriers with regard to brain activity during a semantic categorization task. Test groups were closely matched for sex, age and education. Critically, both groups were cognitively intact and thus symptom-free of Alzheimer's disease. APOE epsilon4 carriers showed reduced task-related responses in the left inferior parietal cortex, and bilaterally in the anterior cingulate region. A dose-related response was observed in the parietal area such that diminution was most pronounced in homozygous compared with heterozygous carriers. In addition, contrasts of processing novel versus familiar items revealed an abnormal response in the right hippocampus in the APOE epsilon4 group, mainly expressed as diminished sensitivity to the relative novelty of stimuli. Collectively, these findings indicate that gene...Continue Reading

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Jan 19, 1990·Science·E Tulving, D L Schacter
Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·W J StrittmatterA D Roses
Jul 1, 1997·Neurobiology of Aging·H Braak, E Braak
Mar 1, 1995·NeuroImage·K J FristonR Turner
Apr 18, 1998·Proceedings of the National Academy of Sciences of the United States of America·T GrunwaldC E Elger
Aug 13, 1998·Journal of Neural Transmission. Supplementum·M GrundmanL J Thal
Mar 11, 1999·Annals of Neurology·J L Price, J C Morris
Jul 17, 1999·Human Brain Mapping·K A KiehlR D Hare
Dec 22, 1999·Drugs & Aging·L FratiglioniH Agüero-Torres
May 17, 2000·Proceedings of the National Academy of Sciences of the United States of America·G W SmallM E Phelps
Aug 17, 2000·The New England Journal of Medicine·S Y BookheimerG W Small
Nov 14, 2000·Cerebral Cortex·A D WagnerR L Buckner
Mar 10, 2001·Brain and Cognition·M GrossmanP Koenig
Jan 16, 2002·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Alison C BurggrenSusan Y Bookheimer
Apr 4, 2002·Proceedings of the National Academy of Sciences of the United States of America·Rachael I ScahillNick C Fox
Jun 18, 2002·Journal of Cellular and Molecular Medicine·A Cedazo-Mínguez, R F Cowburn
Nov 5, 2002·NeuroImage·Murray GrossmanCorey McMillan
Jan 23, 2003·Brain : a Journal of Neurology·Murray GrossmanUNKNOWN fMRI study. Functional magnetic resonance imaging
Apr 17, 2003·British Medical Bulletin·Ahmad R Hariri, Daniel R Weinberger

❮ Previous
Next ❯

Citations

Oct 3, 2007·Archives of General Psychiatry·Sterling C JohnsonMark A Sager
Feb 27, 2008·European Journal of Nuclear Medicine and Molecular Imaging·Marc WermkeAlexander Drzezga
Mar 11, 2010·Acta Neuropathologica·Ditte Z ChristensenOliver Wirths
May 4, 2007·Neuropsychology Review·Christina E Wierenga, Mark W Bondi
Feb 24, 2012·Neuropsychology Review·Markus DonixSusan Y Bookheimer
Sep 27, 2012·Brain Imaging and Behavior·Krishna T PatelLance O Bauer
Mar 25, 2010·Journal of the International Neuropsychological Society : JINS·Ivar ReinvangThomas Espeseth
Sep 8, 2010·Molecular Psychiatry·V HeiseC E Mackay
Dec 16, 2010·Proceedings of the National Academy of Sciences of the United States of America·Lars NybergLars-Göran Nilsson
Jun 12, 2009·Brain : a Journal of Neurology·J L WoodardS M Rao
Mar 24, 2007·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·Cindy M de FriasLars-Göran Nilsson
Mar 31, 2009·Annual Review of Clinical Psychology·Susan Bookheimer, Alison Burggren
Nov 16, 2012·PloS One·Laurence O'DwyerHarald Hampel
Dec 15, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·William J JagustUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Mar 23, 2011·International Journal of Alzheimer's Disease·Elizabeth R Tuminello, S Duke Han
Feb 11, 2014·Cell Metabolism·Sophie StukasCheryl L Wellington
Apr 29, 2014·Neurobiology of Aging·Jonas PerssonLars Nyberg
Feb 6, 2016·Topics in Magnetic Resonance Imaging : TMRI·Ryan A FisicaroAndrei I Holodny
Jul 5, 2011·Progress in Neurobiology·David PrvulovicHarald Hampel
Jul 16, 2011·International Journal of Alzheimer's Disease·Katell MevelBéatrice Desgranges
May 7, 2011·International Journal of Alzheimer's Disease·Meredith N BraskiePaul M Thompson
Jun 23, 2009·Psychiatry Research·Hamid Reza NaghaviLars Nyberg
May 5, 2009·Neuroscience Letters·Thomas EspesethIvar Reinvang
Apr 7, 2011·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Nektaria Nicolakakis, Edith Hamel
Dec 9, 2008·Experimental Gerontology·Simona De BlasiGiuseppe Passarino
Oct 14, 2008·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Gerdien KramerCornelis J Stam
Oct 8, 2008·Neurobiology of Aging·K B WalhovdUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Aug 2, 2008·Journal of the Neurological Sciences·Samantha GalluzziGiovanni B Frisoni
May 2, 2008·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Eric M FineMark W Bondi
Apr 1, 2008·Methods : a Companion to Methods in Enzymology·Alexander Drzezga

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

Alzheimer's Disease: Early Markers

Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive and behavioral decline. Targeting markers in the earliest stages of the disease may mitigate the progression of AD. This feed focuses on early diagnosis and markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.